Viral gene expression and provirus load of Orf-A defective FIV in lymphoid tissues and lymphocyte subpopulations of neonatal cats during acute and chronic infections

Virus Research

Volumn 130, Issue 1-2, 2007, Pages 110-120

  Novak, Janelle M ^a   Crawford, P Cynthia ^a   Kolenda Roberts, Holly M ^a   Johnson, Calvin M ^b   Mergia, Ayalew ^a  

^a University of Florida   (United States)

^b AUBURN UNIVERSITY   (United States)

Author keywords

Cats; FIV; Lymph node; Lymphocytes; Orf A; PBMCs; Thymus

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4 CD8 RATIO; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; FELINE IMMUNODEFICIENCY VIRUS; GENE EXPRESSION; HEMATOLOGICAL PARAMETERS; HUMAN; HUMAN CELL; LYMPHOCYTE SUBPOPULATION; LYMPHOID TISSUE; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROVIRUS; REAL TIME POLYMERASE CHAIN REACTION; VIRUS GENE; VIRUS INFECTION; VIRUS LOAD; VIRUS REPLICATION;

ACUTE DISEASE; ANIMALS; ANIMALS, NEWBORN; CAT DISEASES; CATS; CHRONIC DISEASE; DNA, VIRAL; GENE EXPRESSION; GENE EXPRESSION PROFILING; IMMUNODEFICIENCY VIRUS, FELINE; LENTIVIRUS INFECTIONS; LYMPHOCYTE SUBSETS; LYMPHOID TISSUE; PROVIRUSES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; VIRAL PROTEINS;

ANIMALIA; FELINE IMMUNODEFICIENCY VIRUS;

EID: 35748937048     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2007.06.001     Document Type: Article

References (41)

1. Ackley C.D., Yamamoto J.K., Levy N., Pedersen N.C., and Cooper M.D. Immunological abnormalities in pathogen free cats experimentally infected with feline immunodeficiency virus. J. Virol. 64 (1990) 5652-5655
2. Baba T.W., Jeong Y.S., Pennick D., Bronson R., Greene M.F., and Ruprecht R.M. Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques. Science 267 (1995) 1820-1825
3. Barlough J.E., Ackley C.D., George J.W., Levy N., Acevedo R., Moore P.F., Rideout B.A., Cooper M.D., and Pedersen N.C. Acquired immune dysfunction in cats with experimentally induced feline immunodeficiency virus infection: comparison of short-term and long-term infections. J. AIDS 4 (1990) 219-227
4. Bellah J.R., and Bubenik L.J. Infectivity assay (virus yield assay). In: Aldovini A., and Walker B.D. (Eds). Techniques in HIV Research (1998), Stockton Press, New York 71-76
5. Berger E.A., Murphy P.M., and Farber J.M. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu. Rev. Immunol. 17 (1999) 657-700
6. Crawford P.C., Papadi G.P., Levy J.K., Benson N.A., Mergia A., and Johnson C.M. Tissue dynamics of CD8 lymphocytes that suppress viral replication in cats infected neonatally with feline immunodeficiency virus. J. Infect. Dis. 184 (2001) 671-681
7. Davidson-MG, Rottman J., English R.V., Lapin M.R., and Tompkins M.B. Feline immunodeficiency virus predisposes cats to acute generalized toxoplasmosis. Am. J. Pathol. 143 (1993) 1486-1497
8. De Parseval A., Chatterji U., Sun P., and Elder J.H. Feline immunodeficiency virus targets activated CD4+ T cells by using CD134 as a binding receptor. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 13044-13049
9. De Parseval A., and Elder J.H. Demonstration that orf2 encodes the feline immunodeficiency virus transactivating (Tat) protein and characterization of a unique gene product with partial rev activity. J. Virol. 73 1 (1999) 608-617
10. Dean G.A., Himathongkham S., and Sparger E.E. Differential cell tropism of feline immunodeficiency virus molecular clones in vivo. J. Virol. 73 4 (1999) 2596-2603
11. Gemeniano M.C., Sawai E.T., Leutenegger C.M., and Sparger E.E. Feline immunodeficiency virus ORF-Ais required for virus particle formation and virus infectivity. J. Virol. 77 (2003) 8819-8830
12. Gemeniano M.C., Sawai E.T., and Sparger E.E. Feline immunodeficiency virus Orf-A localizes to the nucleus and induces cell cycle arrest. Virology 325 (2004) 167-174
13. Inoshima Y., Kohmoto M., Ikeda Y., Yamada H., Kawaguchi Y., Tomonaga K., Miyazawa T., Kai C., Umemura T., and Mikami T. Roles of the auxiliary genes and AP-1 binding site in the long terminal repeat of feline immunodeficiency virus in the early stage of infection in cats. J. Virol. 70 12 (1996) 8518-8526
14. Kestler H.W., Ringler D.J., Mori K., Panicali D.L., Sehgal D.L., Daniel M.D., and Desrosiers R.C. Importance of the nef gene for maintenance of high virus loads for developments of AIDS. Cell 65 (1991) 651-662
15. Kiyomasu T., Miyazawa T., Furuya T., Shibata R., Sakai H., Sakuragi J., Fukasawa M., Maki N., Hasegawa A., Mikami T., and Adachi A. Identification of feline immunodeficiency virus rev gene activity. J. Virol. 65 (1991) 4539-4542
16. Lee M.H., Sano K., Morales F.E., and Imagawa D.T. Sensitive reverse transcriptase assay to detect and quantitate human immunodeficiency virus. J. Clin. Microbiol. 25 (1987) 1717-1721
17. McChesney M.B., and Oldstone M.B.A. Virus induced immunsuppression: infections with measles virus and human immunodeficiency virus. Adv. Immunol. 45 (1989) 335-380
18. Norway R.M., Crawford P.C., Johnson C.M., and Mergia A. Thymic lesions in cats infected with a pathogenic molecular clone or an ORF-A/2 deficient molecular clone of Feline Immunodeficiency Virus. J. Virol. 75 (2001) 5833-5841
19. Olmsted R.A., Barnes A.K., Yamamoto J.K., Hirsch V.M., Purcell R.H., and Kohnson P.R. Nucleotide sequence analysis of feline immunodeficiency virus: Genome organization and relationship to other lentiviruses. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 8088-8092
20. Orandle M.S., Crawford P.C., Levy J.K., Udoji R., Papadi G.P., Ciccarone T., Mergia A., and Johnson C.M. CD8+ thymic lymphocytes express reduced levels of CD8beta and increased interferon gamma in cats perinatally infected with the JSY3 molecular clone of feline immunodeficiency virus [In Process Citation]. AIDS Res. Hum. Retrovirus. 16 15 (2000) 1559-1571
21. Orandle M.S., Papadi G.P., Bubenik L.J., Dailey C.I., and Johnson C.M. Selective thymocyte depletion and immunoglobulin coating in the thymus of cats infected with feline immunodeficiency virus. AIDS Res. Hum. Retrovirus. 13 7 (1997) 611-620
22. Pedersen N.C. Feline syncytium-forming virus infection. In: Pratt P.W., and Aiello S.E. (Eds). Feline Infectious Diseases (1989), American Veterinary Publications, Inc., Goleta 77-82
23. Pedersen N.C., Ho E.W., Brown M.L., and Yamamoto J.K. Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science 235 4790 (1987) 790-793
24. Phillips T.R., Larmont C., Konings D., Shacklett B.L., Hamson C.A., Luciw P.A., and Elder J.H. Identification of the Rev transactivation and Rev-responsive elements of feline immunodeficiency virus. J. Virol. 66 (1992) 5464-5471
25. Phillips T.R., Talbott R.L., Lamont C., Muir S., Lovelace K., and Elder J.H. Comparison of two host cell range variants of feline immunodeficiency virus. J. Virol. 64 10 (1990) 4605-4613
26. Pistello M., Bonci F., Isola P., Mazzetti P., Merico A., Zaccaro L., Matteucci D., and Bendinelli M. Evaluation of feline immunodeficiency virus ORF-A mutants as candidate attenuated vaccine. Virology 332 (2005) 676-690
27. Pistello M., Moscardini M., Mazzetti P., Bonci F., Zaccaro L., Isola P., Freer G., Specter S., Matteucci D., and Bendinelli M. Development of feline immunodeficiency virus ORF-A (tat) mutants: in vitro and in vivo characterization. Virology 298 (2002) 84-95
28. Rigby M.A., Hosie M.J., Willett B.J., Mackay N., McDonald M., Cannon C., Dunsford T., Jarrett O., and Neil J.C. Comparative efficiency of feline immunodeficiency virus infection by DNA inoculation. AIDS Res. Hum. Retrovirus. 13 (1997) 405-412
29. Sattentau Q.J., and Weiss R.A. The CD4 antigen: physiological ligand and HIV receptor. Cell 52 (1988) 631-633
30. Shacklett B.L., and Luciw P.A. Analysis of the vif gene of feline immunodeficiency virus. Virology 204 (1994) 860-867
31. Shimojima M., Miyazawa T., Ikeda Y., McMonagle E.L., Haining H., Akashi H., Takeuchi Y., Hosie M.J., and Willett B.J. Use of CD134 as a primary receptor by the feline immunodeficiency virus. Science 303 (2004) 1192-1195
32. Sparger E.E., Beebe A.M., Dua N., Himathongkam S., Elder J.H., Torten M., and Higgins J. Infection of cats with molecularly cloned and biological isolates of the feline immunodeficiency virus. Virology 205 2 (1994) 546-553
33. Sparger E.E., Louie H., Ziomeck A.M., and Luciw P.A. Infection of cats by injection with DNA of a feline immunodeficiency virus molecular clone. Virology 238 (1997) 157-160
34. Sparger E.E., Shacklett B.L., Renshaw-Gegg L., Barry P.A., Pedersen N.C., Elder J.H., and Luciw P.A. Regulation of gene expression directed by the long terminal repeat of the feline immunodeficiency virus. Virology 187 (1992) 165-177
35. Talbot R.T., Sparger E.E., Lovelace K.M., Fitch W.M., Pedersen N.C., Luciw P.A., and Elder J.H. Nucleotide sequence and genomic organization of feline immunodeficiency virus. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 5743-5747
36. Tomonaga K., Shin Y.-S., Fukasawa M., Miyazawa T., Adachi A., and Mikami T. Feline immunodeficiency virus gene expression: analysis of the RNA splicing pattern and monocistronic rev mRNA. J. Gen. Virol. 74 (1993) 2409-2417
37. Waters A.K., De Parseval A.P., Lerner D.L., Neil J.C., Thompson F.J., and Elder J.H. Influence of ORF2 on host cell tropism of feline immunodeficiency virus. Virology 215 1 (1996) 10-16
38. Willett B.J., Flynn J.N., and Hosie M.J. FIV infection of the domestic cat: an animal model for AIDS. Immunol. Today 18 4 (1997) 182-189
39. Willett B.J., Picard L., Hosie M.J., Turner J.D., Adema K., and Clapham P.R. Shared usage of the chemokine receptor CXCR4 by the feline and human immunodeficiency viruses. J. Virol. 71 (1997) 6407-6415
40. Yamamoto J.K., Hansen H., Ho W.E., et al. Epidemiologic and clinical aspects of feline immunodeficiency virus infection in cats from the continental United States and Canada and possible mode of transmission. J. Am. Vet. Med. Assoc. 194 (1989) 213-220
41. Yang J.S., English R.V., Ritchey J.W., Davidson M.G., Wasmoen T., Levy J.K., Gebhard D.H., Tompkins M.B., and Tompkins W.A. Molecularly cloned feline immunodeficiency virus NCSU1 JSY3 induces immunodeficiency in specific-pathogen-free cats. J. Virol. 70 5 (1996) 3011-3017